Atlas Trials

Antilipidemic Ezetimibe Induces Regression of Endometriotic Explants in a Rat Model of Endometriosis

Clinical trial NCT04844996 · COMPLETED

Trial details

NCT number
NCT04844996
Sponsor
Mersin University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Endometriosis
Start date
2019-09-01
Primary completion
2019-12-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.